Clinical Trial Update: First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 [Phase 1]

View source ↗

Summary

The document reports the completion of a first-in-human Phase 1 study evaluating NOX-H94 for safety, tolerability and pharmacokinetics/pharmacodynamics, with an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• NOX-H94

Snippet

Sponsor: TME Pharma AG | Conditions: Anemia, Chronic Diseases | Phase 1 | Status: COMPLETED